Search

Your search keyword '"Yassi, Nawaf"' showing total 691 results

Search Constraints

Start Over You searched for: Author "Yassi, Nawaf" Remove constraint Author: "Yassi, Nawaf"
691 results on '"Yassi, Nawaf"'

Search Results

1. Evolution of white matter hyperintensity segmentation methods and implementation over the past two decades; an incomplete shift towards deep learning

4. Influence of Comorbidity of Cerebrovascular Disease and Amyloid-β on Alzheimer’s Disease

5. Tenecteplase versus alteplase for thrombolysis in patients selected by use of perfusion imaging within 4·5 h of onset of ischaemic stroke (TASTE): a multicentre, randomised, controlled, phase 3 non-inferiority trial

6. Tranexamic acid versus placebo in individuals with intracerebral haemorrhage treated within 2 h of symptom onset (STOP-MSU): an international, double-blind, randomised, phase 2 trial

9. Safety and Outcomes of Intravenous Thrombolytic Therapy in Ischemic Stroke Patients with COVID-19: CASCADE Initiative

10. Thrombolysis for Wake-Up Stroke Versus Non–Wake-Up Unwitnessed Stroke: EOS Individual Patient Data Meta-Analysis

11. Cerebral Edema in Patients With Large Hemispheric Infarct Undergoing Reperfusion Treatment

12. Zinc Supplementation with or without Additional Micronutrients Does Not Affect Peripheral Blood Gene Expression or Serum Cytokine Level in Bangladeshi Children.

15. Stroke Care Trends During COVID-19 Pandemic in Zanjan Province, Iran. From the CASCADE Initiative: Statistical Analysis Plan and Preliminary Results

16. Call to Action: SARS-CoV-2 and CerebrovAscular DisordErs (CASCADE).

18. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial

19. Comparison of tenecteplase with alteplase for the early treatment of ischaemic stroke in the Melbourne Mobile Stroke Unit (TASTE-A): a phase 2, randomised, open-label trial

20. Evaluating the Safety and Efficacy of Telemedicine Physician Assessments on a Mobile Stroke Unit: Protocol for a Prospective Open-Label Blinded End-Point Randomized Controlled Trial.

21. NK1 tachykinin receptor antagonist treatment reduces cerebral edema and intracranial pressure in an ovine model of ischemic stroke.

22. Elevated plasma neurofilament light and glial fibrillary acidic protein in epilepsy versus nonepileptic seizures and nonepileptic disorders.

23. Tenecteplase Treatment and Thrombus Characteristics Associated With Early Reperfusion: An EXTEND-IA TNK Trials Analysis

24. Tranexamic acid in patients with intracerebral haemorrhage (STOP-AUST): a multicentre, randomised, placebo-controlled, phase 2 trial

26. External Validation of a Model for Persistent Perfusion Deficit in Patients With Incomplete Reperfusion After Thrombectomy: EXTEND-PROCEED.

27. Contextualising the benefits and risks of anti‐amyloid therapy for patients with Alzheimer disease and their care team.

33. Microvascular Dysfunction in Blood-Brain Barrier Disruption and Hypoperfusion Within the Infarct Posttreatment Are Associated With Cerebral Edema

39. Rates of age- and amyloid β-associated cortical atrophy in older adults with superior memory performance

41. Data Augmentation Using Synthetic Lesions Improves Machine Learning Detection of Microbleeds from MRI

43. Age, sex, and setting in the etiology of stroke study (ASSESS): Study design and protocol

44. Penumbral imaging and functional outcome in patients with anterior circulation ischaemic stroke treated with endovascular thrombectomy versus medical therapy: a meta-analysis of individual patient-level data

46. Abstract 052: External Validation of the Prediction Model For Delayed Reperfusion in Patients with Incomplete Reperfusion: EXTEND‐PROCEED

49. Tenecteplase Versus Alteplase Before Endovascular Therapy in Basilar Artery Occlusion

50. Utility of Severity-Based Prehospital Triage for Endovascular Thrombectomy: ACT-FAST Validation Study

Catalog

Books, media, physical & digital resources